

NCT01491763 comparison:

Summary:
CHIA has 13 criteria while your personal folder has 13 criteria
Total found criteria: 13/13
Total not Found: 0/13
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patients with Ph (BCR/ABL) positive de novo < 55   │ Patients with Ph (BCR/ABL) positive de novo \< 55  │
│ years old (it is advisable to include patients     │ years old (it is advisable to include patients     │
│ over 55 years LAL07OPH protocol)                   │ over 55 years LAL07OPH protocol)                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Performance status 0-2 (Appendix B) may include    │ Performance status 0-2 (Appendix B) may include    │
│ patients with performance status > 2 attributable  │ patients with performance status \> 2 attributable │
│ to LAL                                             │ to LAL                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients without functional impairment of organs:  │ Patients without functional impairment of organs:  │
│ liver function: total bilirubin, AST, ALT, alfa-GT │ liver function: total bilirubin, AST, ALT, alfa-GT │
│ and alkaline phosphatase less than 3 times the     │ and alkaline phosphatase less than 3 times the     │
│ upper limit of normal laboratory renal function:   │ upper limit of normal laboratory renal function:   │
│ serum creatinine < 2 mg/dL or clearance creatinine │ serum creatinine \< 2 mg/dL or clearance           │
│ > 30 ml/min (except renal function attributable to │ creatinine \> 30 ml/min (except renal function     │
│ LAL) cardiac function (Appendix B) normal:         │ attributable to LAL) cardiac function (Appendix B) │
│ ventricular EF > 50%, absence of severe chronic    │ normal: ventricular EF \> 50%, absence of severe   │
│ respiratory disease. In the event that alterations │ chronic respiratory disease. In the event that     │
│ are secondary to the disease is at the discretion  │ alterations are secondary to the disease is at the │
│ of the investigator to determine if the patient    │ discretion of the investigator to determine if the │
│ can be included in the trial                       │ patient can be included in the trial               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any other variety of LAL                           │ Any other variety of LAL                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of coronary artery         │ Patients with a history of coronary artery         │
│ disease, valvular or hypertensive heart disease    │ disease, valvular or hypertensive heart disease    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with chronic liver disease                │ Patients with chronic liver disease                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with chronic respiratory failure          │ Patients with chronic respiratory failure          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Renal failure not due to LAL                       │ Renal failure not due to LAL                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with positive HIV status                  │ Patients with positive HIV status                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No serious neurological abnormalities due to LAL   │ No serious neurological abnormalities due to LAL   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Impact on overall severe (grade 3 or 4 of the WHO  │ Impact on overall severe (grade 3 or 4 of the WHO  │
│ scale) not attributable to the LAL                 │ scale) not attributable to the LAL                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant or breastfeeding                          │ Pregnant or breastfeeding                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ initial blast crisis CML                           │ initial blast crisis CML                           │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 55 Years │
╘═══════════════════════════════════╛